AKT1 E17K mutant phosphorylates MDM2

Stable Identifier
R-HSA-2399981
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

AKT1 E17K gain-of-function mutant is expected to phosphorylate MDM2, like the wild-type AKT (Zhou et al. 2001, Feng et al. 2004, Milne et al. 2004), but this has not been experimentally tested.

Literature References
PubMed ID Title Journal Year
15169778 Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation

Feng, J, Tamaskovic, R, Yang, Z, Brazil, DP, Merlo, A, Hess, D, Hemmings, BA

J. Biol. Chem. 2004
15527798 A novel site of AKT-mediated phosphorylation in the human MDM2 onco-protein

Milne, D, Kampanis, P, Nicol, S, Dias, S, Campbell, DG, Fuller-Pace, F, Meek, D

FEBS Lett. 2004
11715018 HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

Zhou, BP, Liao, Y, Xia, W, Zou, Y, Spohn, B, Hung, MC

Nat Cell Biol 2001
Participants
Participates
Catalyst Activity

protein serine/threonine kinase activity of p-T308,S473-AKT1 E17K [cytosol]

Normal reaction
Functional status

Gain of function of p-T308,S473-AKT1 E17K [cytosol]

Status
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Authored
Reviewed
Created
Cite Us!